Zobrazeno 1 - 10
of 757
pro vyhledávání: '"Mark S Soloway"'
Autor:
Elie Antebi, Ahmed Eldefrawy, Devendar Katkoori, Cynthia T Soloway, Murugesan Manoharan, Mark S Soloway
Publikováno v:
International Brazilian Journal of Urology, Vol 37, Iss 3, Pp 320-327 (2011)
PURPOSE: The desirable outcomes after open radical prostatectomy (RP) for localized prostate cancer (PC) are to: a) achieve disease recurrence free, b) urinary continence (UC), and c) maintain sexual potency (SP). These 3 combined desirable outcomes
Externí odkaz:
https://doaj.org/article/89bb042ad7f84b039ab86f3c8b0af50e
Publikováno v:
Indian Journal of Urology, Vol 27, Iss 3, Pp 351-356 (2011)
Objectives : Budd-Chiari syndrome (BCS) is a poorly understood entity in urology. It results from obstruction of the hepatic veins and the subsequent complications. It has been infrequently reported to be secondary to hepatic venous obstruction from
Externí odkaz:
https://doaj.org/article/15cf971d07af4ae0b3f513c0238160b7
Autor:
Rajinikanth Ayyathurai, Mark S Soloway
Publikováno v:
Indian Journal of Urology, Vol 27, Iss 2, Pp 238-244 (2011)
Upper urinary tract (UUT) transitional cell carcinoma (TCC) is relatively rare tumor. Approximately 0.7-4% of patients with primary bladder cancer develops UUT-TCC. The symptoms related to an UUT-TCC often occur with an advanced stage which leads one
Externí odkaz:
https://doaj.org/article/101882bc531049758797b5e2f91d4c1c
Autor:
Ahmed Eldefrawy, Mark S Soloway, Devendar Katkoori, Rakesh Singal, David Pan, Murugesan Manoharan
Publikováno v:
Indian Journal of Urology, Vol 28, Iss 4, Pp 424-426 (2012)
Introduction: Chemotherapy was shown to improve survival in patients undergoing radical cystectomy (RC) for muscle-invasive bladder cancer (MIBC). The initiation and completion rates for perioperative chemotherapy are variable. Our aim is to compare
Externí odkaz:
https://doaj.org/article/7ccbe08340d94d8cb064a88287364d59
Autor:
Mark S Soloway
Publikováno v:
Indian Journal of Urology, Vol 27, Iss 2, Pp 215-217 (2011)
Externí odkaz:
https://doaj.org/article/41297aa9b6bc4c6bbab934fa47af4f52
Autor:
Jiaojiao Wang, Andre R. Jordan, Huabin Zhu, Sarrah L. Hasanali, Eric Thomas, Soum D. Lokeshwar, Daley S. Morera, Sung Alexander, Joseph McDaniels, Anuj Sharma, Karina Aguilar, Semih Sarcan, Tianyi Zhu, Mark S. Soloway, Martha K. Terris, Muthusamy Thangaraju, Luis E. Lopez, Vinata B. Lokeshwar
Publikováno v:
Cancer Cell International, Vol 22, Iss 1, Pp 1-18 (2022)
Abstract Background Hyaluronic acid (HA) promotes cancer metastasis; however, the currently approved treatments do not target HA. Metastatic renal carcinoma (mRCC) is an incurable disease. Sorafenib (SF) is a modestly effective antiangiogenic drug fo
Externí odkaz:
https://doaj.org/article/1f1a172dc33d4a4c9e1a7d3503729931
Autor:
Mark S. Soloway
Publikováno v:
Bladder Cancer. :1-7
Autor:
Mark S. Soloway
Publikováno v:
Bladder Cancer. 8:419-422
Autor:
Mark S. Soloway
Publikováno v:
Bladder Cancer. 7:477-480
Autor:
Mark S. Soloway, Neil A. Abrahams
Publikováno v:
Bladder Cancer. 7:99-102